Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Antiviral Research
|
March 8, 2016
HCV evolutionary genetics of SVR versus virologic failure assessed from the vaniprevir phase III registration trials
Steven W Ludmerer, Tomona Hirano, Stuart Black, et al.
The Journal of Biological Chemistry
|
July 26, 2002
Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells
Qun Wu, Paul Kirschmeier, Tish Hockenberry, et al.
Scientific Reports
|
March 13, 2025
An osteobiography of a celebrity chimpanzee reflects the changing roles of modern zoos
David M Cooper, Blessing Chidimuro, Stuart Black, et al.
Journal of Hazardous Materials
|
June 24, 2022
A mechanistic understanding of polyethylene biodegradation by the marine bacterium Alcanivorax
Vinko Zadjelovic, Gabriel Erni-Cassola, Theo Obrador-Viel, et al.
Oncogene
|
April 20, 2002
Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway
Asra Mirza, Marnie McGuirk, Tish N Hockenberry, et al.
Antiviral Therapy
|
September 16, 2014
Generation of a chimeric hepatitis C replicon encoding a genotype-6a NS3 protease and assessment of boceprevir (SCH503034) sensitivity and drug-associated mutations
Amanda L Aloia, Nicholas S Eyre, Stuart Black, et al.
Molecular Biology and Evolution
|
December 28, 2021
Ancient Human Genomes and Environmental DNA from the Cement Attaching 2,000-Year-Old Head Lice Nits
Mikkel W Pedersen, Catia Antunes, Binia De Cahsan, et al.
Antimicrobial Agents and Chemotherapy
|
August 26, 2015
Susceptibilities of genotype 1a, 1b, and 3 hepatitis C virus variants to the NS5A inhibitor elbasvir
Rong Liu, Stephanie Curry, Patricia McMonagle, et al.
Antimicrobial Agents and Chemotherapy
|
August 29, 2018
<i>In Vitro</i> Antiviral Profile of Ruzasvir, a Potent and Pangenotype Inhibitor of Hepatitis C Virus NS5A
Ernest Asante-Appiah, Rong Liu, Stephanie Curry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 1, 2014
Virologic resistance analysis from a phase 2 study of MK-5172 combined with pegylated interferon/ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection
Anita Y M Howe, Stuart Black, Stephanie Curry, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Antiviral Research
|
March 8, 2016
HCV evolutionary genetics of SVR versus virologic failure assessed from the vaniprevir phase III registration trials
Steven W Ludmerer, Tomona Hirano, Stuart Black, et al.
The Journal of Biological Chemistry
|
July 26, 2002
Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells
Qun Wu, Paul Kirschmeier, Tish Hockenberry, et al.
Scientific Reports
|
March 13, 2025
An osteobiography of a celebrity chimpanzee reflects the changing roles of modern zoos
David M Cooper, Blessing Chidimuro, Stuart Black, et al.
Journal of Hazardous Materials
|
June 24, 2022
A mechanistic understanding of polyethylene biodegradation by the marine bacterium Alcanivorax
Vinko Zadjelovic, Gabriel Erni-Cassola, Theo Obrador-Viel, et al.
Oncogene
|
April 20, 2002
Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway
Asra Mirza, Marnie McGuirk, Tish N Hockenberry, et al.
Antiviral Therapy
|
September 16, 2014
Generation of a chimeric hepatitis C replicon encoding a genotype-6a NS3 protease and assessment of boceprevir (SCH503034) sensitivity and drug-associated mutations
Amanda L Aloia, Nicholas S Eyre, Stuart Black, et al.
Molecular Biology and Evolution
|
December 28, 2021
Ancient Human Genomes and Environmental DNA from the Cement Attaching 2,000-Year-Old Head Lice Nits
Mikkel W Pedersen, Catia Antunes, Binia De Cahsan, et al.
Antimicrobial Agents and Chemotherapy
|
August 26, 2015
Susceptibilities of genotype 1a, 1b, and 3 hepatitis C virus variants to the NS5A inhibitor elbasvir
Rong Liu, Stephanie Curry, Patricia McMonagle, et al.
Antimicrobial Agents and Chemotherapy
|
August 29, 2018
<i>In Vitro</i> Antiviral Profile of Ruzasvir, a Potent and Pangenotype Inhibitor of Hepatitis C Virus NS5A
Ernest Asante-Appiah, Rong Liu, Stephanie Curry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 1, 2014
Virologic resistance analysis from a phase 2 study of MK-5172 combined with pegylated interferon/ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection
Anita Y M Howe, Stuart Black, Stephanie Curry, et al.
Page
of 5